|
FY2026
12 months to Mar 31, 2026
|
|
|---|---|
| Net income (loss) | |
| Interest earned on investments held in Trust Account | |
| Prepaid expenses and other current assets | |
| Accrued expenses and other current liabilities | |
| Other receivable | |
| Net cash used in operating activities | |
| Purchase of investments held in Trust Account | |
| Net cash used in investing activities | |
| Proceeds from sale of private units | |
| Proceeds from Initial Public Offering | |
| Payment of underwriter fees | |
| Payment of offering costs | |
| Proceeds from promissory note – related party | |
| Repayment of promissory note – related party | |
| Net cash provided by financing activities | |
| Net Changes in Cash | |
| Cash – Beginning of period | |
| Cash – End of period | |
| Supplemental Disclosure of Non-cash Financing Activities: | |
| Reclassification of negative additional paid-in capital to accumulated deficit | |
| Issuance of Public Rights net of issuance costs of $102,558 | |
| Remeasurement of carrying value to redemption value | |
| Deferred underwriting fee payable | |
| Prior year deferred offering cost charged to additional paid-in capital |
Loading...
